Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

CONTINGENT LIABILITIES, GUARANTEES, COMMITMENTS AND CHARGES (Narrative) (Details)

v3.24.1
CONTINGENT LIABILITIES, GUARANTEES, COMMITMENTS AND CHARGES (Narrative) (Details)
$ in Thousands
 1 Months Ended 12 Months Ended
Jan. 02, 2024
CAD ($)
Nov. 19, 2021
CAD ($)
Nov. 19, 2021
EUR (€)
Sep. 29, 2020
ILS (₪)
Dec. 31, 2022
CAD ($)
Dec. 31, 2022
EUR (€)
Dec. 31, 2023
CAD ($)
Aug. 19, 2019
ILS (₪)
Disclosure of contingent liabilities [abstract]                
Amount of personal suit | ₪               ₪ 15,585
Estimated total amount of class action suit | ₪               ₪ 685,740,000
Amount of expenses paid by applicant | ₪       ₪ 750        
Test kits purchased | €     € 947,563          
Total amount Clongene COVID-19 tests   $ 380,400            
Total amount of placed an order Uniclaro GmbH   $ 4,300            
Amount of payment claim against partial delivery | €     € 941,897.2          
Control of focus fine $ 129,000              
Purchase price for Covid-19 rapid tests         $ 300,000   $ 300,000  
Covid-19 rapid tests, total amount         $ 1,540 € 1,046,010